Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2012 Q2- Text added to 2012 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
7th grade Avg
|
Removed:
active, aimed, April, assistance, Cell, Cobalamin, collaborative, conclusively, conduct, continued, decided, drop, encoding, ending, essential, estimate, existing, expiry, February, force, Foundation, fully, gene, Growth, Human, identified, incur, license, licensing, Modulating, notable, Nucleic, nutrient, office, order, outsourced, overseen, pathway, portfolio, preventing, primarily, produced, proliferation, protein, pursue, receptor, relate, Relating, remain, remaining, result, review, RFSUNY, specific, strategy, SUNY, technology, therapy, Thereof, Transcobalamin, Treating, University, uptake, utilizing, Vitamin, work, York
Valuein 2012 Q2 filing- Value in 2012 Q3 filing
Original filings
Filing view